News

SA hospital system’s nonprofit owner taps new CEO with close ties

Jaime Wesolowski is putting off retirement to become the new CEO of Methodist Healthcare Ministries of ...

StemBioSys CEO: Company has room to grow in San Antonio

Bob Hutchens is CEO of StemBioSys Inc. CARLOS JAVIER SANCHEZ | SABJ By W. Scott Bailey – Senior ...

Events

Medical Devices 101: An Educational Forum

When:  8:00 – 5:00 pm Monday, August 13 Where:  Norris Conference Center, ...
News
Biotech firm's Belgian deal to create dozens of new jobs in San Antonio
June 7, 2016

INCELL Corp. CEO Dr. Mary Pat Moyer will serve as chief science officer for the new joint venture.

W. Scott Bailey
Reporter/Project Coordinator
San Antonio Business Journal

INCELL Corp., a San Antonio-based biotech company, has entered into a joint venture with a Belgian investment group to form a new company called BioTurnKey. The new firm plans to accelerate the development and manufacturing of regenerative and personalized medicine products and services.

INCELL?s deal with the Belgian investor group, formed by Wisetree Invest and 4 for Cells, is expected to result in the creation of 50 new jobs at its San Antonio headquarters in the short term. The longer-term impact on the Alamo City company could be more profound as BioTurnKey grows its client base in the U.S. and abroad.

Dr. Mary Pat Moyer, CEO and chief science officer for INCELL, will also serve as chief science officer for the new joint venture. She said in a press statement that the ?accelerated development, manufacturing and international regulatory harmonization? created as a result of the joint venture will lead to the development of more products to meet more medical needs worldwide.

Stakeholders said BioTurnKey?s unique business model will reduce the time and costs required to commercialize new and innovative tissue, cell, device and drug products that traditionally have taken as long as 10 years or more to get to market.

INCELL, which was founded in 1993, currently employs 25 people. The company manufactures human cell and tissue therapy products, drugs, and medical devices. It also provides product development, testing and research services for other companies.

Stay informed. Subscribe to BioMed SA news alerts.